According to Mars Finance, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) announced plans to acquire $100 million worth of Ethereum in the next 12 months. The company said the move will enhance its corporate strategy in cryptocurrency investment, drug development and asset acquisition.
Publicly listed Propanc Biopharma plans to acquire $100 million in Ethereum
This article is machine translated
Show original
Sector:
Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share